<DOC>
	<DOCNO>NCT00849797</DOCNO>
	<brief_summary>The objective study compare rate extent absorption test formulation oxcarbazepine tablet TrileptalÂ® tablet administer 1 x 600 mg dose fed condition .</brief_summary>
	<brief_title>Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Inclusion Criteria Male female , smoker nonsmoker , 18 year age old . BMI great equal 19.0 less equal 30.0 kg/m2 Exclusion Criteria Subjects follow applies exclude study : Clinically significant illness surgery within 4 week administration study medication . Any clinically significant abnormality abnormal laboratory test result find medical screening . Any reason , opinion medical subinvestigator , would prevent subject participate study . Positive test hepatitis B , hepatitis C HIV screen . ECG abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 90 140 mmHg , diastolic blood pressure low 50 90mmHg ; heart rate less 50 100 bpm ) screening . History significant alcohol abuse drug abuse within one year prior screen visit . Regular use alcohol within six month prior screen visit ( 14 unit alcohol per [ 1 Unit = 150 mL wine 360 mL beer 45 mL 40 % alcohol ] , positive alcohol breath test screening . Use soft drug ( marijuana ) within 3 month screen visit hard drug ( cocaine , phencyclidine ( PCP ) crack ) within 1 year prior screen visit positive urine drug screen screen . History allergic reaction heparin , oxcarbazepine , carbamazepine , relate drug . Use drug know induce inhibit hepatic drug metabolism ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , omeprazole ; examples inhibitor : antidepressant ( SSRI ) , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) within 30 day prior administration study medication . Use investigational drug participation investigation study within 30 day prior dose . Clinically significant history presence gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) , unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug . Any clinically significant history presence neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric , metabolic disease . Use prescription medication within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption . Difficulty swallow study medication . Smoking 25 cigarette per day . Any food allergy , intolerance , restriction special diet , opinion Medical SubInvestigator , could contraindicate subject 's participation study . A depot injection implant drug within 3 month prior administration study medication . Donation plasma ( 500 mL ) within 30 day prior drug administration . Donation loss whole blood ( exclude volume blood drawn screening procedure study ) prior administration study medication follow : 50 mL 300 mL whole blood within 30 day 301 mL 500 mL whole blood within 45 day 500 mL whole blood within 56 day . Consumption food beverage contain grapefruit ( e.g . fresh , canned frozen ) within 7 day prior administration study medication . History presence atreoventricular ( AV ) block . Difficulty fast consume standard meal . Intolerance venipuncture . Clinically significant history renal , hepatic , cardiovascular , tuberculosis , epilepsy , asthma , diabetes , psychosis , glaucoma eligible study . Positive urine pregnancy test screening . Breastfeeding subject . Female subject childbearing potential unprotected sexual intercourse nonsterile male partner within 14 day prior study drug administration . Acceptable method contraception : Intrauterine contraceptive device ( place least 4 week prior study drug administration . Condom diaphragm + spermicide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>